Thursday, April 21, 2022

Alembic Pharmaceuticals – Walk-In Recruitment Drive for QC / QA / Engineering on 26th April’ 2022

 Alembic Pharmaceuticals Limited was established in 1907 with the objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent. Today, Alembic Pharmaceuticals Limited is one of the leading pharmaceutical companies in India. Alembic Pharmaceuticals Limited, a name itself strongly signifies the growth of 115 years. Looking at our tremendous progress and foreseeing our future business plans, Alembic Pharmaceuticals Limited is one of the leading API & Formulations manufacturing and marketing pharmaceutical company. We continue to enjoy leadership positions in antibiotics, anti-infective, anti-cough and also have significant worldwide presence in specialty therapeutic areas such as cardiology, neurology, diabetology, etc. We have newly setup plants of Oncology, General Injectable and Dermaceuticals. Alembic Pharmaceuticals Limited, a name itself strongly signifies the growth of 115 years. Looking at our tremendous progress and foreseeing our future business plans.

 

ALEMBIC PHARMACEUTICALS LTD-WALK-IN RECRUITMENT DRIVE ON 26TH APRIL 2022

WE ARE HIRING!!!

For our Sikkim Domestic Formulation Plant,

we are looking forward to recruit energetic, self-driven health care professional and we invite suitable candidates as follows

  • Designation : Quality Control, Quality Assurance & Engineering
  • Role : Officer/Senior Officer/ Assistant Manager
  • Qualification / Experience Required : B.Sc / B.Pharma / M.Pharm/ M.Sc / B.Tech / Diploma in engineering
  • Experience: 3 to 12 yrs relevant experience

 

Walk-In Recruitment Drive Venue:

WOW HOTEL, INDORE Plot No. 106, Scheme No. 54,PU-3 Commercial, AB Road, Madhya Pradesh, India-452010

Interview Timings: 10:00 A.M. to 07:00 P.M.

FOR MORE DETAILS:

Contact Person: Swapneel Arekar | Mobile – 9960253222 / 9611209806

Email ID: Swapneel.arekar@alembic.co.in

Please carry your CV and relevant documents

 

No comments:

Post a Comment